No profile data available.
PaxMedica, Inc. (PXMD) is a healthcare company in the brain and nerve treatment drugs industry, based in Tarrytown, United States, with about 6 full-time employees.
It reported revenue of $0 for fiscal year 2023, and net income of -$18.29 million. In Q3 2024 (the quarter ended September 30, 2024) revenue was $0. Its market capitalization was $88,385 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 9, 2026.
, a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.
PaxMedica reported $0 in revenue for fiscal year 2023. In Q3 2024 revenue was $0.
$88,385 as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Silo Pharma, Inc. (SILO), Oragenics, Inc. (OGEN), Protagenic Therapeutics, Inc. (PTIX), Seelos Therapeutics, Inc. (SEELQ).